Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients

被引:13
作者
Canale, D [1 ]
Vignali, E [1 ]
Golia, F [1 ]
Martino, E [1 ]
Pinchera, A [1 ]
Marcocci, C [1 ]
机构
[1] Univ Pisa, Osped Cisanello, Dipartimento Endocrinol, I-56124 Pisa, Italy
关键词
hypogonadism; osteoporosis; bone mineral density; bone markers; hormonal replacement treatment;
D O I
10.1016/S0303-7207(99)00223-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We investigated 22 male patients affected by prepubertal hypogonadism with a mean age of 34.3 +/- 5.2. A significant reduction of bone mineral density (BMD) at both the lumbar spine (L2-L4, -14%, 1.039 +/- 0.11 vs. 1.217 +/- 0.16 g/cm(2), P = 0.005) and femoral neck (-11%; 0.927 +/- 0.09 vs. 1.034 +/- 0.16 g/cm(2), P = 0.01) was found in patients compared to age-matched controls. The mean Z score was -1.55 for vertebrae and -1.33 for femur. Eleven and nine patients, respectively, had a lumbar and femoral BMD at least 1 S.D, below the normal mean; 8 and 4, respectively, 2 S.D. below. There was a strong positive correlation between BMD and duration of hormone replacement treatment (HRT) for both sites: respectively, r = 0.71, P < 0.005 for the vertebrae, and r = 0.60, P < 0.01 for the femur. A weak correlation was also present between onset of HRT and BMD: r = 0.6, P < 0.01 at the lumbar level, and r = 0.47, P < 0.05 at the femoral neck. (C) 2000 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 19 条
[1]   ANDROGENS - RISKS AND BENEFITS [J].
BARDIN, CW ;
SWERDLOFF, RS ;
SANTEN, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (01) :4-7
[2]   Long-term effect of testosterone therapy on bone mineral density in hypogonadal men [J].
Behre, HM ;
Kliesch, S ;
Leifke, E ;
Link, TM ;
Nieschlag, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2386-2390
[3]   CRITICAL YEARS AND STAGES OF PUBERTY FOR SPINAL AND FEMORAL BONE MASS ACCUMULATION DURING ADOLESCENCE [J].
BONJOUR, JP ;
THEINTZ, G ;
BUCHS, B ;
SLOSMAN, D ;
RIZZOLI, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :555-563
[4]  
CANALE D, 1990, FERTIL STERIL, V53, P537
[5]   OSTEOPOROSIS IN MEN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
FINKELSTEIN, JS ;
KLIBANSKI, A ;
NEER, RM ;
GREENSPAN, SL ;
ROSENTHAL, DI ;
CROWLEY, WF .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (03) :354-361
[6]   INCREASES IN BONE-DENSITY DURING TREATMENT OF MEN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
FINKELSTEIN, JS ;
KLIBANSKI, A ;
NEER, RM ;
DOPPELT, SH ;
ROSENTHAL, DI ;
SEGRE, GV ;
CROWLEY, WF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (04) :776-783
[7]   OSTEOPENIA IN MEN WITH A HISTORY OF DELAYED PUBERTY [J].
FINKELSTEIN, JS ;
NEER, RM ;
BILLER, BMK ;
CRAWFORD, JD ;
KLIBANSKI, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :600-604
[8]   SPINAL OSTEOPOROSIS IN MEN [J].
FRANCIS, RM ;
PEACOCK, M ;
MARSHALL, DH ;
HORSMAN, A ;
AARON, JE .
BONE AND MINERAL, 1989, 5 (03) :347-357
[9]  
GLODRAY D, 1993, J CLIN ENDOCR METAB, V76, P288
[10]   Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover [J].
Guo, CY ;
Jones, TH ;
Eastell, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :658-665